During 7-13 November, 2012 Farmak JSC was inspected by FDA* to ascertain that Validol tablets are manufactured for the U.S. market in compliance with the cGMP requirements.
Our Company has received a formal response saying that the inspection procedures are completed and Validol-related Production and Quality Systems are assessed as acceptable.
Olga Oleksiichuk, Quality Director says, “For Farmak, it was the first positive experience passing an FDA inspection, during which our specialists could observe FDA’s approaches to interrelated assessment of the six quality systems, including, quality assurance, production, quality control, maintenance and other systems. We saw that the major focus of FDA inspection was given to the issues that pose the biggest consumer safety concern”.
Our specialists have also gained valuable experience of communication with the inspectors and saw how important professionalism and teamwork are. At the same time, we are responsible to assure the continued compliance with the current Good Manufacturing Practice (сGMP).
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...